Ahren et al. in $16m round for Mogrify
A consortium of investors led by existing backer Ahren Innovation Capital has provided UK biotech business Mogrify with a $16m series-A.
More on Expansion
MCF Corporate Finance buys Cubus in debt advisory expansion
Deal with Frankfurt-based firm follows demand for combined M&A and financing services
Holland exits Mauritskliniek in sale to PE-backed Corius
Sale of Dutch dermatology group comes nine months after regulator blocked sale to Triton's Bergman
Verdane invests in Qbtech, Topro via impact fund
Privately-owned ADHD test maker and PE-backed mobility device producer are fourth and fifth deals from Verdane Idun I
FPE Capital invests in Global App Testing
UK-based testing platform marks the third investment of the GP’s GBP 185m third fund
Latest News
Silverfleet to reap 3.1x money from TrustQuay sale to Hg
Exit of UK-based software provider set to generate 40%-plus IRR; Baird advised on auction
Squire Patton Boggs bolsters German PE team with Linklaters hire
New partner Sascha Konwalski joins Frankfurt office; US law firm to open new offices in Europe
Novalpina fund exits Laboratoire XO to Stanley Capital
French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group
EQT bolsters sustainability team with hire from Nordea
Ylva Hannestad joins GP’s client engagement around sustainability agenda